Relievant Medsystems has developed Intracept®, an outpatient, minimally invasive procedure for treating patients with vertebrogenic chronic lower back pain (CLBP). Over five millions Americans experience vertebrogenic CLBP, many of whom do not achieve lasting results after years of cycling through various courses of care. Intracept has shown improvements in both pain and function through two Level I randomised controlled trials and long-term, five-year outcomes data.